Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia

American Journal of Clinical Pathology

Volumn 119, Issue 1, 2003, Pages 61-65

  Refaai, Majed A ^b   Laposata, Michael ^b   Van Cott, Elizabeth M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

ELISA; Heparin; Heparin induced thrombocytopenia; HIT titer; Platelet count; Thrombocytopenia; Thrombosis

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; HEPARIN; THROMBOCYTE FACTOR 4;

ANTIBODY TITER; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; REFERENCE VALUE; REPRODUCIBILITY;

ANTIBODIES; ANTICOAGULANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; HEPARIN; HUMANS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THROMBOCYTOPENIA;

EID: 85047688615     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6922EWGPHVDX9EQJ     Document Type: Article

References (20)

1. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79:1-7.
2. Greinacher A. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost. 1995;21:106-116.
3. Kappers-Klunne MC, Boon DMS, Hop WCJ, et al. Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases. Br J Haematol. 1997;96:442-446.
4. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
5. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci. 1993;305:208-215.
6. Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H, ed. Low-Molecular Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases. New York, NY: Marcel Dekker; 1994:75-127.
7. Baglin TP. Heparin-induced thrombocytopenia/thrombosis syndrome (HIT): diagnosis and treatment. Platelets. 1997;8:72-74.
8. Demasi R, Bode AP, Knupp C, et al. Heparin-induced thrombocytopenia. Am Surg. 1994;60:26-29.
9. Nand S, Wong W, Yuen B, et al. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol. 1997;56:12-16.
10. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101:502-507.
11. Hach-Wunderle V, Kainer K, Salzmann G, et al. Heparin-related thrombosis despite normal platelet counts in vascular surgery. Am J Surg. 1997;173:117-119.
12. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172)). Thromb Haemost. 1993;70:554-561.
13. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1995;69:344-350.
14. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/Heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1995; 104:648-654.
15. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost. 1995;73:21-28.
16. Newman PM, Chong BH. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 2000;96:182-187.
17. Amiral J, Wolf M, Marfaing-Koka A, et al. Characteristics of antibodies to PF4, IL-8, and NAP-2 complexed to heparin in patients with heparin-induced thrombocytopenia: a study of 187 cases [abstract]. Thromb Haemost. 1997; suppl:449.
18. Amiral J, Margaing-Koka A, Wolf M, et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide in patients with heparin-associated thrombocytopenia. Blood. 1996;88:410-416.
19. Walenga JM, Jeske WP, Wood JJ, et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin Hematol. 1999; 36(suppl 1):22-28.
20. Lindhoff-Last E, Gerdsen F, Ackerman H, et al. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 2001;113:886-890.